Ratings Nexam Chemical Holding AB

Equities

NEXAM

SE0005101003

Market Closed - Nasdaq Stockholm 11:08:38 2024-04-26 EDT 5-day change 1st Jan Change
3.16 SEK +0.64% Intraday chart for Nexam Chemical Holding AB -0.32% -5.95%

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
-5.95% 23.32M -
-1.62% 19.88B -
-12.25% 5.32B
A-
+4.34% 4B
B
+1.89% 1.32B
B
-5.86% 1.14B
B-
+25.19% 996M -
-14.91% 674M - -
-22.65% 688M -
-17.53% 277M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. NEXAM Stock
  4. Ratings Nexam Chemical Holding AB